BioHarvest Sciences Inc. Form 6-K Filing

This Form 6-K filing by BioHarvest Sciences Inc. announces the launch of VINIA Daily Chews, a new single-dose format for their VINIA product. This expansion aims to broaden the product's appeal to new demographics and occasions, demonstrating the versatility of their Botanical Synthesis platform. VINIA, derived from red-grape cells, is BioHarvest's first consumer product from this platform. The Daily Chews are presented as a convenient, chewable alternative to capsules, containing 400 mg of VINIA and 6 mg of piceid resveratrol per dose. The company believes this new format will enhance customer engagement and retention, aligning with the growing market for gummy and chewable supplements. This strategic move also serves to showcase BioHarvest's capabilities as a Contract Development and Manufacturing Organization (CDMO) to potential partners, illustrating how their plant-based compositions can be developed and scaled into diverse consumer products. The new VINIA Daily Chews are available for purchase on the company's website.